- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Wayne Burton on the Impact of Workers With Migraine on Employers
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Transcript:
What kind of impact do workers with migraine have on employers? Do employers see a loss of revenue or productivity? How can this be mitigated?
Migraine is extremely important to employers because if you think about migraine headaches, they effect people basically between age 25 and 55—prime age group for workers. Eighteen percent are women, about 6% are men, and it has significant impacts on on-the-job productivity, or so-called presenteeism, as well as direct costs, [like] medical costs [and] pharmacy costs. So, it’s an exceedingly important medical condition for employers.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
